Lina Maria Lopez Nuñez

Dr. Lina Maria Lopez Nuñez

Universidad de La Sabana, Bogotá, Colombia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JPJuan Sebastian Hernández Puentes
Juan Sebastian Hernández Puentes
AGAlirio Rodrigo Bastidas Goyes
Alirio Rodrigo Bastidas Goyes
ETEduardo Tuta-Quintero
Eduardo Tuta-Quintero
JAJuan David Acosta
Juan David Acosta
VFValeria Leyton Franco
Valeria Leyton Franco
ANAvril Johanna Rubio Noel
Avril Johanna Rubio Noel
Background: Obstructive sleep apnea (OSA) is a highly prevalent disorder associated with increased morbidity and mortality. Continuous positive airway pressure (CPAP) remains the first-line therapy, but its long-term effectiveness is limited by suboptimal adherence, with only 50–60% of patients achieving the recommended use. Evidence on adherence with alternative modalities, such as bilevel positive airway pressure (BiPAP) or oxygen therapy, is even more limited. Furthermore, few studies have directly compared these treatments with each other, particularly in relation to survival outcomes. Objective: Evaluate 5-year survival in patients with OSA treated with CPAP, BIPAP, or oxygen therapy. Methods: A retrospective cohort study with survival analysis was conducted in subjects with OSA followed at a tertiary-level institution in Colombia between January 2005 and December 2021. Results: Among 3039 patients with OSA (mean age 59.6 years; 59.8% male), the five-year mortality rate was 5.8%. Deceased patients presented a higher prevalence of comorbidities, including hypertension, diabetes, and cardiovascular disease (all p < 0.001). Adherence to CPAP was significantly lower in deceased patients. Survival analysis showed the highest five-year survival among adherent CPAP/Auto-CPAP users (95.6%), followed by non-adherent CPAP (95%) and adherent BiPAP users (94.1%). Lower survival was observed in non-adherent BiPAP users (91.7%) and oxygen therapy patients (80.6%). In multivariable analysis, treatment type, older age, congestive heart failure, chronic lung disease, and metastatic cancer were independently associated with increased mortality risk. Conclusions: Five-year survival in patients with obstructive sleep apnea was significantly associated with the treatment modality and adherence level.

8 October 2025 in Science Progress
Verified
Journal Article
Open access
JPJuan Sebastian Hernández Puentes
Juan Sebastian Hernández Puentes
AGAlirio Rodrigo Bastidas Goyes
Alirio Rodrigo Bastidas Goyes
ETEduardo Tuta-Quintero
Eduardo Tuta-Quintero
DQDiana Marcela Díaz Quijano
Diana Marcela Díaz Quijano
LNLina Maria Lopez Nuñez
Lina Maria Lopez Nuñez
CMCristhian Fabian Acero Murillo
Cristhian Fabian Acero Murillo
Objective: To evaluate the influence of age, sex, and the need for intensive care unit admission on the clinical outcomes of patients with community-acquired pneumonia (CAP), considering the impact of comorbidities such as cardiovascular diseases, chronic kidney disease, and oncological conditions on the risk of complications and mortality. Methodology: A multicenter retrospective cohort study was conducted in patients with CAP admitted to two tertiary-level institutions in Colombia between January 2010 and December 2020. A comorbidity map (comorbidome) was developed to reflect the prevalence of these conditions according to intensive care unit (ICU) stay, sex, and age. Results: In a cohort of 3370 patients, the most frequent comorbidities were arterial hypertension (50.1%), anemia (31.8%), and chronic pulmonary disease (27.8%). Functional dependency showed the strongest association with mortality (OR 7.17; 95% CI 5.6–9.17), with significant differences in distribution and strength of association according to age, sex, and need for ICU admission. Conclusion: This study demonstrated the high prevalence of comorbidities in patients with CAP in Colombia, highlighting arterial hypertension, anemia, and chronic pulmonary disease as the most common. The distribution of these comorbidities varied according to age and sex, although a very similar clinical profile was observed regarding the need for ICU admission.

Verified
Journal Article
Open access
PDF file
AGAlirio Rodrigo Bastidas Goyes
Alirio Rodrigo Bastidas Goyes
LGLuis Fernando Giraldo-Cadavid
Luis Fernando Giraldo-Cadavid
ETEduardo Tuta-Quintero
Eduardo Tuta-Quintero
DQDiana Marcela Díaz Quijano
Diana Marcela Díaz Quijano
DBDaniel Botero-Rosas
Daniel Botero-Rosas
Juan Sebastian LeonJuan Sebastian Leon
Juan Sebastian Leon
Background/Objective: The morphology of the flow–volume curve has emerged as a potential source of additional functional information by enabling the analysis of concavity, slope-based metrics, area-derived measures, and mathematical models extracted from the expiratory tracing. Therefore, the aim of this study was to map and describe the available evidence on morphological analysis methods of the expiratory flow–volume curve for the identification and characterization of fixed airflow obstruction. Methods: A scoping review was conducted following the methodological frameworks proposed by Arksey and O’Malley, Levac et al., the Joanna Briggs Institute, and the PRISMA Extension for Scoping Reviews (PRISMA-ScR). Studies published between 1 January 1990, and 31 December 2025, that evaluated morphological flow–volume curve metrics for the diagnosis or characterization of Chronic Obstructive Pulmonary Disease (COPD) were included, without language restrictions. Searches were performed in PubMed/MEDLINE, Embase, Scopus, Web of Science, IEEE Xplore, OpenGrey, and Google Scholar. Study selection was conducted by independent reviewers, with disagreements resolved by consensus, and data extraction was performed using a standardized form. Results were synthesized narratively and organized according to metric families. Results: The search identified 13,577 records; after duplicate removal and screening, 24 studies met the inclusion criteria. The evidence included observational studies, diagnostic validation studies, longitudinal cohorts, and methodological modeling studies. Identified metrics were grouped into four main categories: concavity and geometric indices of the flow–volume curve, expiratory slope and flow-decay metrics, area-based or volumetric-derived measures, and mathematical or computational models applied to the tracing. Concavity indices, the β-angle, slope-ratio, Peak Index, and the D parameter showed consistent associations with airflow obstruction, emphysema, small airway disease, or functional impairment. Expiratory slope metrics and Flow Decay demonstrated high diagnostic performance in several studies, whereas area-based measures such as AEX, AEX-FV, AreaFE%, and AUC3/AT3 integrated the overall loss of expiratory flow during forced expiration. Mathematical and computational models suggested that the complete shape of the curve contains additional diagnostic and prognostic information, although methodological variability and the need for external validation remain important limitations. Conclusions: Morphological analysis of the flow–volume curve represents a promising approach to complement conventional spirometry in the identification and characterization of fixed airflow obstruction. These metrics may provide additional information regarding airflow limitation, non-uniform lung emptying, emphysema, small airway disease, hyperinflation, and clinically relevant outcomes.

Verified
Journal Article
Open access
PDF file
JPJuan Sebastian Hernández Puentes
Juan Sebastian Hernández Puentes
AGAlirio Rodrigo Bastidas Goyes
Alirio Rodrigo Bastidas Goyes
ETEduardo Tuta-Quintero
Eduardo Tuta-Quintero
CGCatalina Marenco Galvis
Catalina Marenco Galvis
JCJuanita Fetecua Chaparro
Juanita Fetecua Chaparro
LNLina Maria Lopez Nuñez
Lina Maria Lopez Nuñez
Community-acquired pneumonia is one of the main causes of morbidity and mortality due to infections worldwide. This has led to the study of the use of corticosteroids as adjunctive therapy, which has shown an inclination to provide clinical benefits. However, controversy persists regarding the use of one corticosteroid over another Objectives: Evaluate the outcomes associated with the use of hydrocortisone versus methylprednisolone in patients with community-acquired pneumonia. Methods: We conducted a multicenter retrospective cohort study that included hospitalized adults diagnosed with CAP at two high-complexity clinics in Colombia between 2010 and 2020. Propensity score matching was used in a 1:1 ratio to balance the baseline characteristics between the hydrocortisone and methylprednisolone groups. The primary outcome was 30-day mortality. Secondary outcomes included septic shock, vasopressor use, admission to the intensive care unit, mechanical ventilation, and other hospital outcomes. Survival analyses were performed using Kaplan–Meier curves and estimates of the average treatment effect, as well as subgroup analyses according to the dose and duration of treatment. Results: The study initially included 366 patients, with significant baseline differences between groups. After matching, an adjusted cohort of 168 patients (84 per group) was obtained, with an adequate balance of clinical, paraclinical, and severity-related variables. No statistically significant differences were found in 30-day mortality between patients who received hydrocortisone and those who received methylprednisolone before or after matching. Additionally, no differences were detected in the secondary clinical outcomes. Survival analyses revealed no differences according to corticosteroid type, treatment duration, or administered dose. Conclusions: In this retrospective propensity-score-matched cohort study, no differences were observed in 30-day mortality or other clinical outcomes between hydrocortisone and methylprednisolone in patients with community-acquired pneumonia.